天坛生物
(600161)
| 流通市值：470.45亿 | | | 总市值：470.45亿 |
| 流通股本：16.48亿 | | | 总股本：16.48亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,221,955,159.91 | 5,180,441,799.76 | 4,022,002,501.05 | 2,690,961,828.65 |
| 营业收入 | 1,221,955,159.91 | 5,180,441,799.76 | 4,022,002,501.05 | 2,690,961,828.65 |
| 二、营业总成本 | 722,799,366.81 | 3,429,763,630.82 | 2,618,355,943.43 | 1,784,099,100.49 |
| 营业成本 | 536,722,064.99 | 2,550,720,565.86 | 2,026,717,917.67 | 1,384,891,130.84 |
| 税金及附加 | 12,298,685.35 | 48,639,863.94 | 39,036,600.11 | 26,470,792.78 |
| 销售费用 | 55,529,756.19 | 270,516,563.02 | 198,706,738.14 | 152,953,306.72 |
| 管理费用 | 108,230,333.86 | 469,461,905.96 | 329,484,614.96 | 215,554,763.79 |
| 研发费用 | 24,452,750.69 | 139,949,764.24 | 58,350,420.2 | 25,892,769.65 |
| 财务费用 | -14,434,224.27 | -49,525,032.2 | -33,940,347.65 | -21,663,663.29 |
| 其中:利息费用 | 1,198,479.66 | 3,654,642.64 | 4,046,269.6 | 2,659,574.41 |
| 其中:利息收入 | 12,518,048.15 | 55,526,126.67 | 39,526,970.53 | 25,364,806.22 |
| 加:投资收益 | 10,234,166.63 | 37,213,444.44 | 26,978,444.46 | 16,743,444.43 |
| 资产处置收益 | - | -51,775.39 | -2,085.3 | -2,085.3 |
| 资产减值损失(新) | -243,202.61 | -2,166,905 | -374,756.58 | -173,026.83 |
| 信用减值损失(新) | 87,687.48 | -2,010,176.36 | -1,349,600.16 | -462,116.94 |
| 其他收益 | 7,029,429.74 | 21,331,808.54 | 13,351,350.65 | 11,649,901.49 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 516,263,874.34 | 1,804,994,565.17 | 1,442,249,910.69 | 934,618,845.01 |
| 加:营业外收入 | 102,037.33 | 5,004,027.03 | 1,797,697.74 | 1,037,712.04 |
| 减:营业外支出 | 143,624.07 | 11,400,152.55 | 2,995,823.21 | 598,225.57 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 516,222,287.6 | 1,798,598,439.65 | 1,441,051,785.22 | 935,058,331.48 |
| 减:所得税费用 | 84,095,084.28 | 289,139,647.24 | 233,435,461.56 | 160,856,568.09 |
| 六、净利润 | 432,127,203.32 | 1,509,458,792.41 | 1,207,616,323.66 | 774,201,763.39 |
| 持续经营净利润 | 432,127,203.32 | 1,509,458,792.41 | 1,207,616,323.66 | 774,201,763.39 |
| 归属于母公司股东的净利润 | 316,673,978.07 | 1,109,888,597.22 | 887,400,407.26 | 566,799,608.15 |
| 少数股东损益 | 115,453,225.25 | 399,570,195.19 | 320,215,916.4 | 207,402,155.24 |
| (一)基本每股收益 | 0.19 | 0.67 | 0.54 | 0.34 |
| (二)稀释每股收益 | 0.19 | 0.67 | 0.54 | 0.34 |
| 九、综合收益总额 | 432,127,203.32 | 1,509,458,792.41 | 1,207,616,323.66 | 774,201,763.39 |
| 归属于母公司股东的综合收益总额 | 316,673,978.07 | 1,109,888,597.22 | 887,400,407.26 | 566,799,608.15 |
| 归属于少数股东的综合收益总额 | 115,453,225.25 | 399,570,195.19 | 320,215,916.4 | 207,402,155.24 |
| 公告日期 | 2024-04-26 | 2024-03-29 | 2023-10-26 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |